Euclid BeFree & Peripheral-Defocus Myopia Lenses

Euclid BeFree is a soft myopia-management contact lens from Euclid Systems, a company long known for its orthokeratology lenses. BeFree uses a peripheral-defocus optical design: while the center of the lens corrects your child’s distance vision, the surrounding zones are shaped to focus peripheral light in a way intended to slow the elongation of the eye that causes worsening nearsightedness.

No. Euclid BeFree is not FDA-approved for myopia control in the United States. It is available in certain international markets. We present it here for educational purposes so families understand how peripheral-defocus soft lenses work and where the technology is headed. For treatment today, Dr. Patel recommends options with U.S. regulatory clearance and established clinical evidence.

In a nearsighted eye, standard lenses can focus peripheral light behind the retina, which some research suggests may signal the eye to keep growing longer. Peripheral-defocus myopia-management lenses are designed to move that peripheral focus in front of the retina, creating a cue thought to slow axial elongation. Several of the proven treatments Dr. Patel already offers — including MiSight and Stellest — use variations of this same peripheral-defocus principle.

PersonalEyes offers a full range of established treatments: MiSight 1 Day soft lenses (FDA-approved), orthokeratology (overnight lenses), Stellest spectacle lenses, and low-dose atropine drops. Dr. Patel measures your child’s axial length and progression risk, then recommends the option best suited to your child — and monitors emerging technologies like BeFree so your family stays informed.

Yes. Every child’s eyes and lifestyle are different, and myopia management is highly individualized. Book a consultation and Dr. Patel will review the full landscape — including where non-FDA-approved options like BeFree fit — and build a plan around the treatments that are appropriate and available for your child.